...We Welcome You to the Zenith Epigenetics Hub withIn The AGORACOM COMMUNITY!

Zenith's BET Inhibitor ZEN-3694 is Currently Being Evaluated in Multiple Oncology Clinical Trials

Free
Message: Re: Reports of Exempt Distribution
1
Feb 04, 2023 09:01AM

Has past practice been to date warrants 5  years out?

2
Feb 22, 2023 09:43AM
1
Feb 24, 2023 10:39AM
Share
New Message
Please login to post a reply